Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers

Area of Science:

• Genetics
• Pulmonology
• Epidemiology

Background:

• Genetic associations between tumor necrosis factor (TNF) and chronic obstructive pulmonary disease (COPD) have been reported but often lack replication.
• Lymphotoxin A (LTA) is genetically clustered with TNF, suggesting potential joint roles in disease pathogenesis.

Purpose of the Study:

• To investigate the association between genetic variations in TNF and LTA and lung function variations in a large cohort of smokers.
• To determine if specific TNF and LTA polymorphisms influence the rate of lung function decline or baseline lung function in smokers.

Main Methods:

• Two nested case-control studies were conducted within the National Heart, Lung, and Blood Institute Lung Health Study (LHS) cohort (n=5,887 smokers).
• Subjects were selected based on extreme lung function decline or extreme baseline lung function (FEV1).
• Ten tagging single-nucleotide polymorphisms (SNPs) within the TNF and LTA region were genotyped.

Main Results:

• No significant associations were found between the selected LTA and TNF polymorphisms and either the rate of lung function decline or baseline lung function in the studied smoker populations.
• These findings contrast with some previous reports, particularly those involving the TNF-308 polymorphism in Asian populations.

Conclusions:

• The study did not find evidence supporting a role for the investigated TNF and LTA genetic variants in influencing lung function trajectories in Caucasian smokers.
• Results align with previous research suggesting limited genetic contribution of these specific variants to late-onset COPD in Caucasian individuals.